Abstract
Global protein expression studies, an approach known as “proteomics,” can offer important clues for understanding tumor biology that cannot be obtained by other approaches. Proteomic studies have provided protein expression profiles of tumors that can be used to develop novel diagnostic and therapeutic biomarkers. In this chapter, we describe the strategy and design of proteomic studies, as well as the protocols for tissue sample collection and preparation for biomarker discovery, especially tumor biomarkers, followed by a few examples of our recent proteomic studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Suehara Y (2011) Proteomic analysis of soft tissue sarcoma. Int J Clin Oncol 16:92–100
Kondo T, Hirohashi S (2006) Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 1:2940–2956
Suehara Y, Kondo T, Fujii K et al (2006) Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 6:4402–4409
Kawai A, Kondo T, Suehara Y, Kikuta K, Hirohashi S (2008) Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res 466:2099–2106
Suehara Y, Kikuta K, Nakayama R et al (2009) Anatomic site-specific proteomic signatures of gastrointestinal stromal tumors. Proteomics Clin Appl 3:584–596
Suehara Y, Kikuta K, Nakayama R et al (2009) GST-P1 as a histological biomarker of synovial sarcoma revealed by proteomics. Proteomics Clin Appl 3:623–634
Suehara Y, Kondo T, Seki K et al (2008) Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res 14:1707–1717
Kikuta K, Tochigi N, Shimoda T et al (2009) Nucleophosmin as a candidate prognostic biomarker of Ewing’s sarcoma revealed by proteomics. Clin Cancer Res 15:2885–2894
Suehara Y, Tochigi N, Kubota D et al (2011) Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. J Proteomics 74:829–842
Kikuta K, Tochigi N, Saito S et al (2010) Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics. Proteomics Clin Appl 4:560–567
Kikuta K, Kubota D, Saito T et al (2012) Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics 75:1089–1098
Ericsson C, Nister M (2011) Protein extraction from solid tissue. Methods Mol Biol 675:307–312
Acknowledgments
This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS), a science Grant-in-Aid for Young Scientists B, No-22791405. The authors appreciate critical comments and support from Dr. Makoto Endo and Dr. Eisuke Kobayashi.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Suehara, Y., Kubota, D., Saito, T. (2013). Tissue Sample Preparation for Biomarker Discovery. In: Zhou, M., Veenstra, T. (eds) Proteomics for Biomarker Discovery. Methods in Molecular Biology, vol 1002. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-360-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-360-2_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-359-6
Online ISBN: 978-1-62703-360-2
eBook Packages: Springer Protocols